These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17011364)

  • 1. Adherence, behavior change, and visualization: a qualitative study of the experiences of taking an obesity medication.
    Ogden J; Sidhu S
    J Psychosom Res; 2006 Oct; 61(4):545-52. PubMed ID: 17011364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.
    Schwartz SM; Bansal VP; Hale C; Rossi M; Engle JP
    Obesity (Silver Spring); 2008 Mar; 16(3):623-9. PubMed ID: 18239553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist intervention enhances adherence to orlistat therapy.
    Malone M; Alger-Mayer SA
    Ann Pharmacother; 2003 Nov; 37(11):1598-602. PubMed ID: 14565841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term persistence with orlistat and sibutramine in a population-based cohort.
    Padwal R; Kezouh A; Levine M; Etminan M
    Int J Obes (Lond); 2007 Oct; 31(10):1567-70. PubMed ID: 17420781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial.
    Svendsen M; Rissanen A; Richelsen B; Rössner S; Hansson F; Tonstad S
    Obesity (Silver Spring); 2008 Feb; 16(2):327-33. PubMed ID: 18239640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.
    Svendsen M; Helgeland M; Tonstad S
    J Hum Nutr Diet; 2009 Feb; 22(1):55-63. PubMed ID: 19192027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaining weight after taking orlistat: A qualitative study of patients at 18-months follow-up.
    Hollywood A; Ogden J
    J Health Psychol; 2016 May; 21(5):590-8. PubMed ID: 27165964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
    Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' perceptions and experiences of taking oral glucose-lowering agents: a longitudinal qualitative study.
    Lawton J; Peel E; Parry O; Douglas M
    Diabet Med; 2008 Apr; 25(4):491-5. PubMed ID: 18294222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety profiles of orlistat and sibutramine: results of prescription-event monitoring studies in England.
    Perrio MJ; Wilton LV; Shakir SA
    Obesity (Silver Spring); 2007 Nov; 15(11):2712-22. PubMed ID: 18070762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of osteoporosis medication beliefs and side-effect experiences on non-adherence to oral bisphosphonates.
    McHorney CA; Schousboe JT; Cline RR; Weiss TW
    Curr Med Res Opin; 2007 Dec; 23(12):3137-52. PubMed ID: 17988435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study.
    Richelsen B; Tonstad S; Rössner S; Toubro S; Niskanen L; Madsbad S; Mustajoki P; Rissanen A
    Diabetes Care; 2007 Jan; 30(1):27-32. PubMed ID: 17192328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding eating behaviours in Spanish women enrolled in a weight-loss treatment.
    Barberia AM; Attree M; Todd C
    J Clin Nurs; 2008 Apr; 17(7):957-66. PubMed ID: 18321293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A descriptive study of past experiences with weight-loss treatment.
    Burke LE; Steenkiste A; Music E; Styn MA
    J Am Diet Assoc; 2008 Apr; 108(4):640-7. PubMed ID: 18375220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of intractable constipation with orlistat: a report of three cases.
    Guarino AH
    Pain Med; 2005; 6(4):327-8. PubMed ID: 16083464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical strategies for weight loss in the overweight and obese patient.
    Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orlistat increases serum paraoxonase activity in obese patients.
    Audikovszky M; Pados G; Seres I; Harangi M; Fülöp P; Katona E; Illyés L; Winkler G; Katona EM; Paragh G
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):268-73. PubMed ID: 17134960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.